1. Home
  2. NCRA vs ICCM Comparison

NCRA vs ICCM Comparison

Compare NCRA & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nocera Inc.

NCRA

Nocera Inc.

N/A

Current Price

$1.41

Market Cap

3.5M

ML Signal

N/A

Logo IceCure Medical Ltd.

ICCM

IceCure Medical Ltd.

N/A

Current Price

$0.99

Market Cap

3.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
NCRA
ICCM
Founded
2002
2006
Country
Taiwan
Israel
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Sector
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
3.5M
3.6M
IPO Year
2022
2013

Fundamental Metrics

Financial Performance
Metric
NCRA
ICCM
Price
$1.41
$0.99
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $22.67
AVG Volume (30 Days)
6.7K
★ 133.6K
Earning Date
11-16-2026
11-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $13,627,944.00
N/A
Revenue This Year
N/A
$20.80
Revenue Next Year
N/A
$115.66
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.29
$0.13
52 Week High
$80.40
$9.54

Technical Indicators

Market Signals
Indicator
NCRA
ICCM
Relative Strength Index (RSI) 44.17 51.77
Support Level $1.30 $0.96
Resistance Level $1.83 $2.50
Average True Range (ATR) 0.14 0.11
MACD 0.01 0.06
Stochastic Oscillator 36.33 72.92

Price Performance

Historical Comparison
NCRA
ICCM

About NCRA Nocera Inc.

Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Share on Social Networks: